Knowledge Center
Read the latest reports, white papers, and case studies about how LynxCare is transforming RWE
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Showing number out of number results
OHDSI UK | Integrating advanced NLP techniques with the OMOP CDM enhances the accuracy and completeness of hematologic oncology data
Enhancing Hematologic Oncology Data Capture in the OMOP CDM: Methodological Advances and Challenges
Publication
Oncology
ESMO | Real-world usage and adverse events of immune checkpoint inhibitors (ICI): a large-scale, automated, GDPR-compliant analysis of hospital records
Discover the initial findings of a multi-center study into the real-world usage and adverse events of immune checkpoint inhibitors.
Publication
Oncology
ESMO | Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: Evidence from a Belgian real-world multicenter study
Learn more on the results of a multi-center study on cardiovascular toxicities in 1500+ real-world cancer patients treated with immune checkpoint inhibitors
Publication
Immuno-Oncology
OHDSI Europe | Lung Cancer Patient Treatment with Immune Checkpoint Inhibitors: Multicenter, NLP-guided Data Extraction from EHRs
Analysis of Lung Cancer Patient Treatment with Immune Checkpoint Inhibitors Using Natural Language Processing for Data Extraction from Electronic Health Records
Publication
Oncology
European Lung Cancer Congress | Poster | Real-World Evidence of Immune Checkpoint Inhibitor Treatment in Lung Cancer Patients from a Belgian Multicenter Study
Discover the initial findings of the ICI-treated lung cancer patient cohort of 730+ patients regarding demographic and clinical characteristics, ICI treatments, and overall survival (OS).
Publication
Oncology
aTTR-CM | Video | Combining clinical expertise and NLP-AI technology to help in earlier detecting rare diseases
In collaboration with Heart Center Aalst, we conducted a study in which complete Electronic Health Records of patients were processed and analyzed using LynxCare’s cutting-edge clinical NLP-AI technology in search of phenotypes compatible with aTTR-CM, a rare cardiac disease.
Video
Rare diseases
ESMO Immuno-Oncology | Poster | Real-World Insights on Pan-Cancer Immune Checkpoint Inhibitor Treatment: Initial Findings of a Belgian Multicenter Study
To bridge the gap between clinical trial patients and real-world populations, we conducted a comprehensive study in Belgium to characterize cancer patients treated with immune checkpoint inhibitors (ICIs), which have demonstrated survival advantages in various cancer types.
Publication
Oncology
ISPOR Europe | Poster | Building Federated Data Networks with Common Data Models to Generate Insights through Real-World Evidence Observational Studies in Oncology
Accessing and standardizing raw clinical data across multiple hospitals presents a challenge in Oncology. However, it is crucial to use real-world data sources such as electronic health records (EHR) to leverage untapped information. We are building a federated data network to facilitate GDPR-compliant data exchange of large datasets, with hospitals as owners. This network, governed by a common data model (CDM), is aimed at fostering multicenter, observational, real-world evidence (RWE) studies in Oncology, with breast cancer, lung cancer, and immunotherapy as therapeutic areas of focus.
Publication
Oncology
Heart Failure | Use Case | Using AI and NLP on EHRs of Heart Failure patients to examine the impact of estimated glomerular filtration rate trend on mortality
This study aimed to investigate the prevalence of impaired renal function at the time of Heart Failure diagnosis and its correlation with short and long-term outcomes in a real-world cohort of Heart Failure patients.
Case Study
Cardiology
Unfortunately we have no content fit for sharing on our website yet. Reach out to our experts to find out how we are making a difference in this therapeutic area.
Meet us at
Curious what LynxCare can do for you?
”We're an active contributor to establishing the pan-European Health Data Evidence Network (EHDEN) and are eager to contribute to building the European Health Data Space to make a more inclusive European healthcare system for all patients.”
Georges De Feu
Co-founder & CEO, LynxCare
